Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03707821 · ClinicalTrials.gov registry record · NA

Design Validation of Senofilcon A With New UV-blocking Additive

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
253
Enrollment target
10
Study locations

NCT03707821 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 253 participants, above the 127-participant average among 20 other Visual Acuity trials with a reported enrollment target (99% higher). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03707821, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
253 participants
Enrollment target
10
Study locations

Study Summary

This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.

Conditions Studied

Visual Acuity

Interventions

  • DEVICE senofilcon A TEST Lens
  • DEVICE senofilcon A CONTROL Lens

Study Locations (10)

Florida

  • Maitland Vision Center - Maitland
  • Tallahassee Eye Center - Tallahassee

Ohio

  • ProCare Vision Centers - Granville
  • Professional Vision Care, Inc - Westerville

California

  • James T. Fujimoto, OD - Cupertino

Illinois

  • Eyecare Associates LLP - Bloomington

Kansas

  • Kannarr Eye Care - Pittsburg

Tennessee

  • Bradley Hines, OD - Memphis

Texas

  • Frazier Vision, Inc - Tyler

Wisconsin

  • Ziegler Leffingwell Eyecare - New Berlin

Trial Details

FieldValue
Enrollment Target 253 participants
Start Date 2018-10-01
Est. Completion 2018-11-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03707821

The ClinicalTrials.gov registry entry for NCT03707821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 253 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 127-participant average among 20 other Visual Acuity trials with a reported enrollment target (99% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A TEST Lens is the first listed.

NCT03707821 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Ohio, California.

Frequently Asked Questions

What is clinical trial NCT03707821 about?

NCT03707821 is a clinical study titled "Design Validation of Senofilcon A With New UV-blocking Additive". This is a 2-visit, multi-site, partially subject-masked, 2-arm parallel, controlled, randomized and dispensing trial. Subjects will be randomized to one of two study lenses for the entire duration of the study. The study lenses will be worn for a period of 2 weeks each in a bilateral fashion.

What is the current status of trial NCT03707821?

This trial is currently completed. It is a NA study. The enrollment target is 253 participants. The study started on 2018-10-01. Estimated completion is 2018-11-01.

What conditions does trial NCT03707821 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT03707821?

The interventions under investigation include: senofilcon A TEST Lens (DEVICE), senofilcon A CONTROL Lens (DEVICE).

Who is sponsoring clinical trial NCT03707821?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03707821 being conducted?

This trial has 10 study locations across California, Florida, Illinois, Kansas, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Visual Acuity

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.